News for Merck & Co., Inc. (MRK)

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA). This shot shields infants up to the age of one from the respiratory syncytial virus during their first RSV period. RSV refers […]

Currently, Merck stock shows potential for another collar setup, with defined risk and reward, though I haven't executed a new trade yet. Read why MRK is a Buy.

Merck & Co., Inc. (NYSE:MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ETCompany ParticipantsDean Y.

Summary: Merck (MRK) receives FDA approval for its promising new RSV treatment, entering a competitive market. Analyst price targets suggest significant

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the ACIP has triggered a decline in shares of pharmaceutical companies like Novavax (NVAX), Pfizer (PFE), and Merck (MRK) in after-hours trading. Kennedy’s overhaul, aimed at restoring public trust in vaccine science, raises concerns…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIAâ„¢

Merck (MRK) has received approval from the U.S. Food and Drug Administration for enflonsia, a new preventive treatment aimed at protecting neonates and infants

Looking into the current session, Merck & Co Inc. MRK shares are trading at $79.28, after a 0.40% spike. Moreover, over the past month, the stock went up by 3.4...

Key Points: Merck's (MRK) late-stage trial success for its cholesterol drug enlicitide decanoate spurs a premarket stock increase. Analysts forecast a 28

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Alejandro Lopez-Lira has been impressed with how current AI models can trade markets.

**media[648003,648004]**

Merck secures U.S. Patent Office backing in its legal battle with Halozyme over Keytruda's injectable version. Read more here.

PR NewswireNEW YORK, June 2, 2025 NEW YORK, June 2, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

Discover this week's dividend highlights, including increases from Chubb & Global Ship Lease, and upcoming ex-dividend dates for Chevron, Alcoa, and more.

As May draws to a close, it's time to turn our attention to the FDA's upcoming slate of decisions. The following biotech companies are awaiting potential approvals in June 2025.

LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. ( RPID) (the ”œCompany” or ”œRapid Micro”), an innovative life sciences

Rapid Micro Biosystems (RPID) appoints Dr. Dafni Bika to its Board of Directors. Dr. Bika has over 25 years of experience in pharmaceutical development

LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative l...